The Canada pharmaceutical market size and share is currently valued at USD 48.62 billion in 2023. It is anticipated to generate an estimated revenue of USD 88.11 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 6.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024-2032. The key market players include AbbVie, AstraZeneca, Eli Lilly, F. Hoffmann-La Roche, GlaxoSmithKline, Johnson & Johnson,
The global generic oncology drugs market was $18,190 mn in 2018 and is expected to generate around $27,815 mn by 2025, at a CAGR of 6.3% between 2019 and 2025.
The global Organ Preservation market accounted for $229.1 Mn in 2020 and is expected to reach $360.8 Mn by 2028, growing at a CAGR of 5.6% from 2021 to 2028.